ONTOLOGY REPORT - ANNOTATIONS
| Term: | clonidine (amino form) |
|
| Accession: | CHEBI:46632
|
browse the term
|
| Definition: | An imidazoline that has formula C9H9Cl2N3. |
| Synonyms: | exact_synonym: | N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine |
| | related_synonym: | 2-(2,6-dichloroanilino)-1,3-diazacyclopentene-(2); 2-(2,6-dichloroanilino)-2-imidazoline; C9H9Cl2N3; Clc1cccc(Cl)c1NC1=NCCN1; InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14); InChIKey=GJSURZIOUXUGAL-UHFFFAOYSA-N |
| | xref_casrn: | 4205-90-7 |
| | xref: | Beilstein:883415 "Beilstein Registry Number"; ChemIDplus:4205-90-7 "CAS Registry Number" |
| | xref_mesh: | MESH:D003000 |
| | cyclic_relationship: | is_tautomer_of CHEBI:3757 |
|
|
clonidine (amino form)
|
| G |
Adora1 |
adenosine A1 receptor |
|
multiple interactions |
EXP |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
multiple interactions |
ISO |
3 |
114,867,357 |
114,869,680 |
RGD:6480464 |
CTD |
| G |
Adra2c |
adrenoceptor alpha 2C |
|
multiple interactions |
ISO |
14 |
81,107,907 |
81,109,610 |
RGD:6480464 |
CTD |
| G |
Adra2c |
adrenoceptor alpha 2C |
|
increases response to substance |
EXP |
14 |
81,107,907 |
81,109,610 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa2 |
apolipoprotein A-II |
|
decreases expression |
ISO |
13 |
87,114,734 |
87,116,372 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
increases expression |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
increases expression |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Gal |
galanin/GMAP prepropeptide |
|
increases activity |
EXP |
1 |
205,936,352 |
205,941,215 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
increases expression |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
increases expression |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
increases secretion |
EXP |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
increases secretion |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
EXP |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
increases expression |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
increases expression |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
increases expression |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
increases expression |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gnai1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
affects response to substance |
ISO |
4 |
12,465,089 |
12,495,028 |
RGD:6480464 |
CTD |
| G |
Gnai3 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
|
affects response to substance |
ISO |
2 |
203,668,275 |
203,706,229 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
increases expression |
EXP |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
increases expression |
EXP |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
increases secretion |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
EXP |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
EXP |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
decreases secretion |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases expression |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
decreases expression |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
increases expression |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
multiple interactions |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
EXP |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
increases response to substance |
EXP |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Pdcd4 |
programmed cell death 4 |
|
decreases expression |
ISO |
1 |
260,183,648 |
260,202,032 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
increases expression |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
decreases expression |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
increases secretion |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
increases expression |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
decreases activity |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
decreases expression |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases activity |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
multiple interactions |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
decreases activity |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
decreases activity |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
decreases expression |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
decreases activity |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases activity |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tpd52 |
tumor protein D52 |
|
increases expression |
ISO |
2 |
94,850,203 |
94,880,802 |
RGD:6480464 |
CTD |
Term paths to the root
|